INVO Fertility (IVF) Income from Continuing Operations (2011 - 2026)
INVO Fertility's (IVF) quarterly Income from Continuing Operations came in at 1747819.0 in Q1 2026, up 89.96% year-on-year from 920112.33 in Q1 2025, and up 33.91% on a QoQ basis from 2644625.0 in Q3 2025.
INVO Fertility (IVF) Income from Continuing Operations (2011 - 2026) Analysis & Trends
INVO Fertility (IVF) has 16 years of Income from Continuing Operations data on file, last reported at 1747819.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 89.96% year-over-year to 1747819.0 in Q1 2026; TTM through Mar 2026 was 25005124.0, a 0.07% change from a year earlier, with the FY2024 full-year figure at 9214629.0, down 15.11% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 1747819.0, up from 2644625.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for IVF reached as high as 1248440.0 in Q3 2023 and fell as low as 17403586.0 in Q1 2025.
- Historically, Income from Continuing Operations has averaged 3330699.25 across 5 years, with a median of 2550251.0 in 2022.
- Across the five-year window, Income from Continuing Operations slumped 2818.28% in 2022 and soared 89.96% in 2026, its largest moves.
- Year by year, Income from Continuing Operations stood at 2766721.0 in 2022, then advanced by 28.98% to 1965047.0 in 2023, then slumped by 90.44% to 3742284.0 in 2024, then advanced by 29.33% to 2644625.0 in 2025, then surged by 33.91% to 1747819.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 1747819.0 in Q1 2026, 2644625.0 in Q3 2025, and 3209094.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | INVO Fertility | 1,108.74 | -4.90 Mn | 732,978.00 | -1.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.75 Mn |
| Sep 30, 2025 | -2.64 Mn |
| Jun 30, 2025 | -3.21 Mn |
| Mar 31, 2025 | -17.40 Mn |
| Dec 31, 2024 | -3.74 Mn |
| Sep 30, 2024 | -1.63 Mn |
| Jun 30, 2024 | -2.25 Mn |
| Mar 31, 2024 | -1.60 Mn |
| Dec 31, 2023 | -1.97 Mn |
| Sep 30, 2023 | -1.25 Mn |
| Jun 30, 2023 | -2.24 Mn |
| Mar 31, 2023 | -2.55 Mn |
| Dec 31, 2022 | -2.77 Mn |
| Sep 30, 2022 | -2.55 Mn |
| Jun 30, 2022 | -2.80 Mn |
| Mar 31, 2022 | -2.95 Mn |
| Dec 31, 2021 | 101,782.00 |
| Sep 30, 2021 | -2.48 Mn |
| Jun 30, 2021 | -1.82 Mn |
| Mar 31, 2021 | -2.45 Mn |